Cognano

Converge Bio

The company develops AI software for antibody design and optimization to assist pharmaceutical firms in drug discovery and development.

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.

Relation Therapeutics

This biotechnology firm develops an artificial intelligence platform to identify and validate therapeutic drug targets for pharmaceutical companies and research partners.

Khumbu

This company develops artificial intelligence models for molecular biology and protein-ligand interactions to accelerate drug discovery for the pharmaceutical industry.

Immunara

This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.